SC 13G/A

Names of Reporting Persons

Spindletop Healthcare Capital, L.P.

Check the Appropriate Box if a Member of a Group

(a) ☐ (b) ☐

SEC Use Only

Citizenship or Place of Organization

Delaware

SC 13G/A 1 d894018dsc13ga.htm SC 13G/A SC 13G/A

Securities and Exchange Commission

Washington, D.C. 20549

Schedule 13G

(Rule 13d-102)

Information to be Included in Statements Filed Pursuant

to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed

Pursuant to § 240.13d-2

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No.1)*

Bioventus Inc.

(Name of Issuer)

Class A Common Stock

(Title of Class of Securities)

09075A108

(CUSIP Number)

September 30, 2024

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. 09075A108		Schedule 13G		Page 1 of 8


CUSIP No. 09075A108		Schedule 13G		Page 2 of 8


CUSIP No. 09075A108		Schedule 13G		Page 3 of 8


CUSIP No. 09075A108		Schedule 13G		Page 4 of 8


CUSIP No. 09075A108		Schedule 13G		Page 5 of 8

ITEM 1. (a)

Name of Issuer:

Bioventus Inc. (the “Issuer”).

(b)

Address of Issuer’s Principal Executive Offices:

4721 Emperor Boulevard, Suite 100, Durham, North Carolina 27703

ITEM 2. (a)

Name of Person Filing:

Each of the following is hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This statement is filed on behalf of:

Spindletop Healthcare Capital, L.P.

Spindletop Capital GP, L.P.

Spindletop GP Management, LLC

Evan S. Melrose

(b)

Address or Principal Business Office:

The principal business address of each of the Reporting Persons is 3571 Far West Boulevard, PMB #108, Austin, Texas 78731.

(c)

Citizenship of each Reporting Person is:

Evan S. Melrose is a citizen of the United States. Each of the other Reporting Persons is organized under the laws of the state of Delaware.

(d)

Title of Class of Securities:

Class A Common Stock, $0.001 par value per share (“Class A Common Stock”).

(e)

CUSIP Number:

09075A108

ITEM 3.

Not applicable.


CUSIP No. 09075A108		Schedule 13G		Page 6 of 8

ITEM 4.

Ownership.

(a-c)

This amendment to Schedule 13G is being filed to report that, as of the date hereof, the Reporting Persons do not beneficially own any shares of Common Stock.

ITEM 5.

Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☒

ITEM 6.

Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

ITEM 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not applicable.

ITEM 8.

Identification and Classification of Members of the Group.

Not applicable.

ITEM 9.

Notice of Dissolution of Group.

Not applicable.

ITEM 10.

Certification.

Not applicable.


CUSIP No. 09075A108		Schedule 13G		Page 7 of 8

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: November 8, 2024


Spindletop Healthcare Capital, L.P.

By:		Spindletop Capital GP, L.P., its general partner

By:		Spindletop GP Management, LLC, its general partner

By:		/s/ Evan Melrose
Name:		Evan Melrose
Title:		Manager

Spindletop Capital GP, L.P.

By:		By: Spindletop GP Management, LLC, its general partner

By:		/s/ Evan Melrose
Name:		Evan Melrose
Title:		Manager

Spindletop GP Management, LLC

By:		/s/ Evan Melrose
Name:		Evan Melrose
Title:		Manager

Evan S. Melrose

/s/ Evan S. Melrose


CUSIP No. 09075A108		Schedule 13G		Page 8 of 8

LIST OF EXHIBITS


Exhibit No.		Description

99		Joint Filing Agreement (previously filed).

Amendment: SEC Form SC 13G/A filed by Bioventus Inc.